β-Adrenergic Receptor Stimulation Maintains NCX-CaMKII Axis and Prevents Overactivation of IL6R-Signaling in Cardiomyocytes upon Increased Workload
Authors:
- Ingrid MatzerIMIngrid Matzer
- Julia VoglhuberJVJulia Voglhuber
- Mara KiesslingMKMara Kiessling
- Nataša DjalinacNDNataša Djalinac
- Viktoria Trummer-HerbstVTViktoria Trummer-Herbst
- Nishani MabotuwanaNMNishani Mabotuwana
- Lavinia RechLavinia Rech
- Michael HolzerMHMichael Holzer
- Samuel SossallaSSSamuel Sossalla
- Peter P. RainerPRPeter P. Rainer
- Andreas ZirlikAZAndreas Zirlik
- Senka Ljubojevic-HolzerSLSenka Ljubojevic-Holzer
Open Access
- 8 July 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (7) , 1648
Abstract
Excessive β-adrenergic stimulation and tachycardia are potent triggers of cardiac remodeling; however, their exact cellular effects remain elusive. Here, we sought to determine the potency of β-adrenergic stimulation and tachycardia to modulate gene expression profiles of cardiomyocytes. Using neonatal rat ventricular cardiomyocytes, we showed that tachycardia caused a significant upregulation of sodium–calcium exchanger (NCX) and the activation of calcium/calmodulin-dependent kinase II (CaMKII) in the nuclear region. Acute isoprenaline treatment ameliorated NCX-upregulation and potentiated CaMKII activity, specifically on the sarcoplasmic reticulum and the nuclear envelope, while preincubation with the β-blocker propranolol abolished both isoprenaline-mediated effects. On a transcriptional level, screening for hypertrophy-related genes revealed tachycardia-induced upregulation of interleukin-6 receptor (IL6R). While isoprenaline prevented this effect, pharmacological intervention with propranolol or NCX inhibitor ORM-10962 demonstrated that simultaneous CaMKII activation on the subcellular Ca2+ stores and prevention of NCX upregulation are needed for keeping IL6R activation low. Finally, using hypertensive Dahl salt-sensitive rats, we showed that blunted β-adrenergic signaling is associated with NCX upregulation and enhanced IL6R signaling. We therefore propose a previously unrecognized protective role of β-adrenergic signaling, which is compromised in cardiac pathologies, in preventing IL6R overactivation under increased workload. A better understanding of these processes may contribute to refinement of therapeutic options for patients receiving β-blockers.Keywords
Funding Information
- Austrian Science Fund (V-530, I 4168-B)
- ERA-CVD/Austrian Science Fund (FWF), AIR-MI (V-530, I 4168-B)
This publication has 43 references indexed in Scilit:
- Mechanisms of Altered Ca 2+ Handling in Heart FailureCirculation Research, 2013
- Ca2+-calmodulin-dependent protein kinase II regulation of cardiac excitation-transcription couplingHeart Rhythm, 2011
- In Situ Calibration of Nucleoplasmic versus Cytoplasmic Ca2+ Concentration in Adult CardiomyocytesBiophysical Journal, 2011
- Impaired β‐adrenergic responsiveness accentuates dysfunctional excitation–contraction coupling in an ovine model of tachypacing‐induced heart failureThe Journal of Physiology, 2011
- β-Adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII/AP-1 signaling pathway in adult cardiomyocytesJournal of Molecular and Cellular Cardiology, 2010
- Propranolol Blocks Cardiac and Neuronal Voltage-Gated Sodium ChannelsFrontiers in Pharmacology, 2010
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- Does Contractile Ca 2+ Control Calcineurin-NFAT Signaling and Pathological Hypertrophy in Cardiac Myocytes?Science Signaling, 2008
- Mechanisms of postinfarct left ventricular remodelingDrug Discovery Today: Disease Mechanisms, 2007
- Interleukin-6 Family of Cytokines Mediates Isoproterenol-induced Delayed STAT3 Activation in Mouse HeartJournal of Biological Chemistry, 2003